These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 29247988)

  • 21. Interleukin-18 in pediatric rheumatic diseases.
    Prencipe G; Bracaglia C; De Benedetti F
    Curr Opin Rheumatol; 2019 Sep; 31(5):421-427. PubMed ID: 31192813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convergent pathways of the hyperferritinemic syndromes.
    Schulert GS; Canna SW
    Int Immunol; 2018 Apr; 30(5):195-203. PubMed ID: 29420734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of interleukin (IL)-18 receptor alpha chain expression on CD4(+) T cells during T helper (Th)1/Th2 differentiation. Critical downregulatory role of IL-4.
    Smeltz RB; Chen J; Hu-Li J; Shevach EM
    J Exp Med; 2001 Jul; 194(2):143-53. PubMed ID: 11457889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression, purification and structural analysis of human IL-18 binding protein: a potent therapeutic molecule for allergy.
    Kimura T; Kato Z; Ohnishi H; Tochio H; Shirakawa M; Kondo N
    Allergol Int; 2008 Dec; 57(4):367-76. PubMed ID: 18797176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1 Family Blockade in Cytokine Storm Syndromes.
    Cron RQ
    Adv Exp Med Biol; 2024; 1448():553-563. PubMed ID: 39117838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production.
    Fukushima K; Ikehara Y; Yamashita K
    J Biol Chem; 2005 May; 280(18):18056-62. PubMed ID: 15760905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-18: a regulator of cancer and autoimmune diseases.
    Esmailbeig M; Ghaderi A
    Eur Cytokine Netw; 2017 Nov; 28(4):127-140. PubMed ID: 29478963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease.
    Kawashima M; Yamamura M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Miyawaki S; Amano T; Takeuchi T; Makino H
    Arthritis Rheum; 2001 Mar; 44(3):550-60. PubMed ID: 11263769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of IFN-gamma in Th1 differentiation: IFN-gamma regulates IL-18R alpha expression by preventing the negative effects of IL-4 and by inducing/maintaining IL-12 receptor beta 2 expression.
    Smeltz RB; Chen J; Ehrhardt R; Shevach EM
    J Immunol; 2002 Jun; 168(12):6165-72. PubMed ID: 12055229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel anti-human IL-1R7 antibody reduces IL-18-mediated inflammatory signaling.
    Li S; Jiang L; Beckmann K; Højen JF; Pessara U; Powers NE; de Graaf DM; Azam T; Lindenberger J; Eisenmesser EZ; Fischer S; Dinarello CA
    J Biol Chem; 2021; 296():100630. PubMed ID: 33823154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Interleukin 18/Interleukin 18-Binding Protein in Adult-Onset Still's Disease and Systemic Juvenile Idiopathic Arthritis.
    Girard-Guyonvarc'h C; Harel M; Gabay C
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.
    Sareneva T; Julkunen I; Matikainen S
    J Immunol; 2000 Aug; 165(4):1933-8. PubMed ID: 10925275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The family of the interleukin-1 receptors.
    Boraschi D; Italiani P; Weil S; Martin MU
    Immunol Rev; 2018 Jan; 281(1):197-232. PubMed ID: 29248002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
    Verhagen CE; de Boer T ; Smits HH; Verreck FA; Wierenga EA; Kurimoto M; Lammas DA; Kumararatne DS; Sanal O; Kroon FP; van Dissel JT ; Sinigaglia F; Ottenhoff TH
    J Exp Med; 2000 Aug; 192(4):517-28. PubMed ID: 10952721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating IL-18 Binding Protein (IL-18BP) and IL-18 as Dual Biomarkers of Total-Body Irradiation in Mice.
    Ha CT; Li X; Fu D; Xiao M
    Radiat Res; 2016 Apr; 185(4):375-83. PubMed ID: 27023262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-18 and IL-18BP in inflammatory dermatological diseases.
    Wang X; Wang L; Wen X; Zhang L; Jiang X; He G
    Front Immunol; 2023; 14():955369. PubMed ID: 36742296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis.
    Gerdes N; Sukhova GK; Libby P; Reynolds RS; Young JL; Schönbeck U
    J Exp Med; 2002 Jan; 195(2):245-57. PubMed ID: 11805151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP.
    Fabbi M; Carbotti G; Ferrini S
    J Leukoc Biol; 2015 Apr; 97(4):665-75. PubMed ID: 25548255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
    Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
    J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.